ADAM10 and Alzheimer disease: Of particular importance is the finding that OG markedly reduced cerebral amyloidosis, together with enhanced α-CTF and sAPPα production as well as ADAM10 maturation, in a mouse model of AD (Tg2576 mice; Fig. 5A–C, 6A, B).